Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

MEC Plus

Events

Speciality

Type of Media

Author / Speaker

Title

Search Entries:

«
1
…
57
58
59
60
61
…
100
»

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

Jane Lowe Meisel, MD

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

HER2-Driven Breast Cancer: Current Status and Next Generation Therapeutics

Jane Lowe Meisel, MD

Breast Cancer Immunotherapy

Breast Cancer Immunotherapy

Joyce O’Shaugnessy, MD

Breast Cancer Immunotherapy

Breast Cancer Immunotherapy

Joyce O’Shaugnessy, MD

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Krishna V. Komanduri, MD

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies

Krishna V. Komanduri, MD

Chronic Lymphocytic Leukemias

Chronic Lymphocytic Leukemias

Jose Sandoval Sus, MD, FACP

Chronic Lymphocytic Leukemias

Chronic Lymphocytic Leukemias

Jose Sandoval Sus, MD, FACP

B-Cell Lymphomas: Updates and Future Directions

B-Cell Lymphomas: Updates and Future Directions

Eduardo Sotomayor, MD

B-Cell Lymphomas: Updates and Future Directions

B-Cell Lymphomas: Updates and Future Directions

Eduardo Sotomayor, MD

Multiple Myeloma

Multiple Myeloma

Sergio Giralt, MD

Multiple Myeloma

Multiple Myeloma

Sergio Giralt, MD

Metastatic Colorectal Cancer Therapy

Metastatic Colorectal Cancer Therapy

Richard D. Kim, MD

Metastatic Colorectal Cancer Therapy

Metastatic Colorectal Cancer Therapy

Richard D. Kim, MD

Gastric and Esophageal Cancer Updates

Gastric and Esophageal Cancer Updates

Caio Rocha-Lima, MD, MS

Gastric and Esophageal Cancer Updates

Gastric and Esophageal Cancer Updates

Caio Rocha-Lima, MD, MS

Predictive and Prognostic Biomarkers for IO: Value of TMB, MSI, PD-L1 and Others in Liquid and Solid Tumor Specimens

Predictive and Prognostic Biomarkers for IO: Value of TMB, MSI, PD-L1 and Others in Liquid and Solid Tumor Specimens

Alberto Chiappori, MD

Predictive and Prognostic Biomarkers for IO: Value of TMB, MSI, PD-L1 and Others in Liquid and Solid Tumor Specimens

Predictive and Prognostic Biomarkers for IO: Value of TMB, MSI, PD-L1 and Others in Liquid and Solid Tumor Specimens

Alberto Chiappori, MD

Clinical Utility and Future indications of Liquid Biopsies in Lung Cancer

Clinical Utility and Future indications of Liquid Biopsies in Lung Cancer

Benjamin Levy, MD

Clinical Utility and Future indications of Liquid Biopsies in Lung Cancer

Clinical Utility and Future indications of Liquid Biopsies in Lung Cancer

Benjamin Levy, MD

Stage III NSCLC: Beyond the PACIFIC/Novel Approaches

Stage III NSCLC: Beyond the PACIFIC/Novel Approaches

Jorge E. Gomez, MD

Stage III NSCLC: Beyond the PACIFIC/Novel Approaches

Stage III NSCLC: Beyond the PACIFIC/Novel Approaches

Jorge E. Gomez, MD

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

George R. Simon, MD, FACP, FCCP

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC

George R. Simon, MD, FACP, FCCP

Lung Cancer Neoadjuvant and Adjuvant Immunotherapy

Lung Cancer Neoadjuvant and Adjuvant Immunotherapy

Luis E Raez, MD, FACP, FCCP

Lung Cancer Neoadjuvant and Adjuvant Immunotherapy

Lung Cancer Neoadjuvant and Adjuvant Immunotherapy

Luis E Raez, MD, FACP, FCCP

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Stephen V. Liu, MD

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Stephen V. Liu, MD

Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations

Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations

Edgardo S. Santos, MD, FACP

Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations

Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations

Edgardo S. Santos, MD, FACP

Displaying 1,741 - 1,770 of 2,995

«
1
…
57
58
59
60
61
…
100
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok